Trans-Pacific Partnership (TPP) Leaked Texts June-September 2011
October 31, 2011 in United States
The following texts were obtained and first published by Citizens Trade Campaign (CTC). According to CTC, the texts “reveal that the Obama administration has reversed reforms designed to enhance access to affordable medicines made during the George W. Bush administration and is instead demanding new rights for pharmaceutical firms to challenge pricing and other drug formulary policies used by many developed countries to keep down prices.” The texts also have relevance for those studying intellectual property rights as previously leaked versions of the Trans-Pacific Partnership (TPP) demonstrated a number of features that advanced controversial aspects of U.S. copyright law.
(texts at link in PDF)
http://publicintelligence.net/trans-pacific-partnership-tpp-leaked-texts-june-september-2011/Leaked Trans-Pacific Free Trade Agreement Texts Reveal U.S. Pushing Extreme Pharmaceutical Corporation Demands that Would Undermine Consumers’ Access to Affordable Medicine
Obama Administration Positions Roll Back Initial 2007 Reforms Made by Bush Administration on Medicines Patents, Abandon Access to Medicines Commitments
Leaks of U.S. proposals for the Trans-Pacific Free Trade Agreement (FTA) reveal that the Obama administration has reversed reforms designed to enhance access to affordable medicines made during the George W. Bush administration and is instead demanding new rights for pharmaceutical firms to challenge pricing and other drug formulary policies used by many developed countries to keep down prices. The leaked draft text raises multiple concerns, including the following:
EMPOWERING BIG PHARMA TO ATTACK COST-SAVING DRUG FORMULARIES
This is a new proposal to empower pharmaceutical firms to attack the medicine formulary systems that New Zealand, Australia and other developed countries have used so successfully to reduce sky-high drug prices. Governments use formularies to control health costs by listing medicines approved for government purchase or reimbursement and negotiating with drug firms to obtain the lowest prices. Using the Trans-Pacific FTA to undermine Australia’s Pharmaceutical Benefits Scheme (PBS) and New Zealand’s Pharmaceutical Management Agency (PHARMAC) is a goal U.S. pharmaceutical firms. U.S. states and some U.S. national programs also use formulary systems.
http://www.citizenstrade.org/ctc/blog/2011/10/22/leaked-trans-pacific-fta-texts-reveal-u-s-undermining-access-to-medicine/